Bright Minds Biosciences Inc.
DRUG | NASDAQ
$61.44
+$1.98 (+3.33%)
Sep 22, 2026, 12:23 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 19.97K | 20.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -19.97K | -20.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.73M | -15.57M | -6.9M | -5.66M | -3.3M | -3.35M | -1.62M | -791.31K | 234.74K | -558.06K | -1.7M | -1.55M | -1.43M | -2.05M | -2.3M | -3.01M | -2.66M | -4.48M | -4.82M | -2.97M | -3.65M | -1.55M | -617.22K |
Interest Income | 2.87M | 2.73M | 818.27K | 529.54K | 476.23K | 509.38K | 4.32K | 6.01K | 14.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.46M | -10.63M | -7.57M | -4.09M | -5.24M | -2.95M | 49.61K | -773.44K | 229.9K | -574.14K | -1.68M | -1.53M | -1.46M | -2.05M | -2.34M | -2.96M | -2.66M | -4.49M | -4.86M | -2.87M | -3.53M | -1.58M | -677.06K |
Net Income | -2.46M | -10.63M | -7.57M | -4.09M | -5.24M | -2.95M | 49.61K | -773.44K | 229.9K | -574.14K | -1.68M | -1.53M | -1.46M | -2.05M | -2.34M | -2.96M | -2.66M | -4.49M | -4.86M | -2.87M | -3.53M | -1.58M | -677.06K |
Selling & General & Admin | 2.22M | 2.23M | 1.09M | 756.41K | 591.94K | 676.16K | 540.93K | 351.01K | 320.64K | 363.6K | 401.18K | 459.16K | 380.32K | 562.64K | 797.69K | 430.86K | 603.28K | 640.58K | 876.35K | 744.99K | 887.05K | 447.89K | 210.55K |
Research & Development | 9.5M | 13.27M | 5.66M | 4.78M | 2.69M | 2.56M | 1.05M | 416.06K | -566.75K | 105.18K | 1.23M | 1.09M | 1.05M | 1.4M | 1.46M | 2.54M | 2.05M | 3.74M | 3.85M | 2.21M | 2.71M | 1.04M | 352.79K |
Other Expenses | n/a | 54.62K | 154.22K | 123.93K | 12.52K | 112.84K | 38.36K | 24.24K | 11.36K | 89.29K | 72.29K | 0 | 0 | 93.09K | 40.92K | 39.12K | 8.01K | 93.51K | 102.44K | 13.5K | 52.33K | 62.04K | 53.88K |
Operating Expenses | 11.71M | 15.55M | 6.9M | 5.66M | 3.3M | 3.35M | 1.62M | 791.31K | -234.74K | 558.06K | 1.7M | 1.55M | 1.43M | 2.05M | 2.3M | 3.01M | 2.66M | 4.48M | 4.82M | 2.97M | 3.65M | 1.55M | 617.22K |
Interest Expense | 4.17K | 5.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 102.13K | 99.1K | 152.44K | 112.68K | 86.34K | 78.2K | 5K | n/a | n/a | 36.6K | 36.6K | 37.1K | 4.65K | 41.07K | 74.59K | 80.12K | 176.87K | 220.28K | 146.46K | 473.53K | 218.88K | 13.29K |
Cost & Expenses | 11.73M | 15.57M | 6.9M | 5.66M | 3.3M | 3.35M | 1.62M | 791.31K | -234.74K | 558.06K | 1.7M | 1.55M | 1.43M | 2.05M | 2.3M | 3.01M | 2.66M | 4.48M | 4.82M | 2.97M | 3.65M | 1.55M | 617.22K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 9.83M | 9.59M | 7.76M | 7.17M | 7.08M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 3.84M | 3.77M | 3.77M | 3.79M | 3.59M | 2.98M | 2.37M | 2.37M | 2.37M | 2.37M | 2.26M | 1.39M | 1.16M |
Shares Outstanding (Diluted) | 9.83M | 9.59M | 7.76M | 7.17M | 7.08M | 4.65M | 4.65M | 4.65M | 4.65M | 4.46M | 3.84M | 3.77M | 3.77M | 3.79M | 3.59M | 2.98M | 2.37M | 2.37M | 2.37M | 2.37M | 2.26M | 1.39M | 1.16M |
EPS (Basic) | -0.26 | -1.12 | -0.97 | -0.41 | -0.74 | -0.66 | 0.01 | -0.17 | 0.05 | -0.13 | -0.44 | -0.41 | -0.39 | -0.56 | -0.68 | -0.98 | -1.12 | -1.90 | -2.05 | -1.21 | -1.56 | -1.14 | -0.65 |
EPS (Diluted) | -0.26 | -1.12 | -0.97 | -0.41 | -0.74 | -0.63 | 0.01 | -0.17 | 0.05 | -0.13 | -0.44 | -0.41 | -0.39 | -0.56 | -0.68 | -0.98 | -1.12 | -1.90 | -2.05 | -1.21 | -1.56 | -1.14 | -0.65 |
EBITDA | -11.71M | -10.61M | -7.55M | -4.07M | -5.23M | -2.93M | 71.14K | -754.42K | 248.02K | -556.03K | -1.67M | 22.48K | -27.29K | -2.03M | -2.32M | -2.96M | -2.66M | -4.49M | -4.86M | -2.87M | -3.53M | -1.55M | -617.22K |
EBIT | -11.73M | -10.63M | -7.57M | -4.09M | -5.24M | -2.95M | 49.61K | -773.44K | 229.9K | -574.14K | -1.68M | -1.53M | -1.46M | -2.05M | -2.34M | -2.96M | -2.66M | -4.49M | -4.86M | -2.87M | -3.53M | -1.55M | -617.22K |
Depreciation & Amortization | 19.97K | 20.13K | 19.79K | 17.01K | 15.85K | 22.48K | 21.53K | 19.02K | 18.11K | 18.11K | 18.11K | 1.55M | 1.43M | 18.11K | 18.11K | 4.62K | 2.65M | 4.38M | 4.72M | 2.95M | 3.6M | 1.49M | 580.55K |
Add to Watchlist
Select watchlists to add or remove DRUG